Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linde

Showing results (51-60 of 6,101) with videos related to

Pageof 611
Sort By:
Forschende Komplementarmedizin (2006)|August 7, 2009
St. John's wort - an overviewKlaus Linde
Zentralblatt Fur Bakteriologie. 1. Abt. Originale. A: Medizinische Mikrobiologie, Infektionskrankheiten Und Parasitologie|January 1, 1981
[High-immunogenic mutants of Salmonella with two independently of each other attenuating markers as potential vaccines from bacteria capable of multiplication. I. communication: usefulness of the purin-auxotrophy for the isolation of high-immunogenic and stable double-marker strains (author's transl)]K Linde
Developments in Biological Standardization|January 1, 1983
Stable, highly immunogenic mutants of "Salmonella" with two independent, attenuating markers as potential live vaccine and their validity for "Shigella" and other bacteriaK Linde
Archiv Fur Experimentelle Veterinarmedizin|January 1, 1982
[Salmonella mutants with reduced generation time]K Linde
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|February 24, 2001
[Autologous plasmapheresis: ingenious coagulation treatment or expensive volume replacement?]I Linde
Positive Living (Los Angeles, Calif.)|May 31, 2002
'Fine tuning' HIV therapy. Report on the 9th Conference on Retroviruses and Opportunistic InfectionsMichael Linde
Reports on Progress in Physics. Physical Society (Great Britain)|January 11, 2017
A brief history of the multiverseAndrei Linde
Heart (British Cardiac Society)|January 20, 2004
Implantable cardioverter-defibrillator treatment and resynchronisation in heart failureCecilia Linde
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|April 1, 2014
[Not Available]K Linde
European Heart Journal|August 26, 2023
The BUDAPEST trial: a good grade for upgrades in heart failure with reduced ejection fractionCecilia Linde
Pageof 611

Showing results (51-60 of 6,101) with videos related to

Sort By:
Pageof 611
Forschende Komplementarmedizin (2006)|August 7, 2009
St. John's wort - an overviewKlaus Linde
Zentralblatt Fur Bakteriologie. 1. Abt. Originale. A: Medizinische Mikrobiologie, Infektionskrankheiten Und Parasitologie|January 1, 1981
[High-immunogenic mutants of Salmonella with two independently of each other attenuating markers as potential vaccines from bacteria capable of multiplication. I. communication: usefulness of the purin-auxotrophy for the isolation of high-immunogenic and stable double-marker strains (author's transl)]K Linde
Developments in Biological Standardization|January 1, 1983
Stable, highly immunogenic mutants of "Salmonella" with two independent, attenuating markers as potential live vaccine and their validity for "Shigella" and other bacteriaK Linde
Archiv Fur Experimentelle Veterinarmedizin|January 1, 1982
[Salmonella mutants with reduced generation time]K Linde
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|February 24, 2001
[Autologous plasmapheresis: ingenious coagulation treatment or expensive volume replacement?]I Linde
Positive Living (Los Angeles, Calif.)|May 31, 2002
'Fine tuning' HIV therapy. Report on the 9th Conference on Retroviruses and Opportunistic InfectionsMichael Linde
Reports on Progress in Physics. Physical Society (Great Britain)|January 11, 2017
A brief history of the multiverseAndrei Linde
Heart (British Cardiac Society)|January 20, 2004
Implantable cardioverter-defibrillator treatment and resynchronisation in heart failureCecilia Linde
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|April 1, 2014
[Not Available]K Linde
European Heart Journal|August 26, 2023
The BUDAPEST trial: a good grade for upgrades in heart failure with reduced ejection fractionCecilia Linde
Pageof 611